Skip to main content
. 2016 Oct 18;6:35468. doi: 10.1038/srep35468

Figure 1. APG enhances TRAIL-induced cell proliferation inhibition of NSCLC cells.

Figure 1

(a) Chemical structure of APG. (b–d) Left, A549 cells (b), H1299 cells (c) and HEK293 cells (d) were treated with TRAIL at different concentrations (0, 15, 30, 45, 60 ng/mL) for 24 h, and the cell viability was assessed by MTT assay. Right, A549 cells (b), H1299 cells (c) and HEK293 cells were treated with TRAIL at the concentration of 25 ng/mL for 24 h in the presence of indicated concentrations of APG. The cell viability was assessed by MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.